Master Delaware Supreme Court clarified the Unocal standard by defining "preclusive" and "coercive" defenses and adopting a "range of reasonableness" test for corporate takeover defenses. with this comprehensive case brief.
Unitrin is a cornerstone Delaware corporate law decision refining the intermediate scrutiny applied to defensive measures that boards adopt in response to hostile takeover bids. Building on Unocal and Paramount v. Time, the Delaware Supreme Court in Unitrin clarified what it means for a defensive measure to be impermissibly "draconian" and articulated how courts should evaluate non-draconian responses. The opinion crystallizes the now-familiar concepts that a response is per se invalid if it is coercive or preclusive; otherwise, it must still fall within a "range of reasonableness" in relation to the threat perceived.
The case is also significant for cementing "substantive coercion"—the risk that stockholders might mistakenly tender into an inadequate offer—as a cognizable threat under Unocal, and for rejecting any requirement that a target's board adopt the "least restrictive" alternative to address a takeover threat. Unitrin thus equips boards with meaningful, but not unbounded, discretion to deploy rights plans and share repurchases, while supplying courts and practitioners with a clearer analytic roadmap for contest-era litigation.
Unitrin, Inc. v. American General Corp., 651 A.2d 1361 (Del. 1995)
American General Corporation (AGC) launched an unsolicited, premium, partial cash tender offer for a significant block of Unitrin, Inc.'s shares, coupled with a proxy effort to replace directors so it could remove Unitrin's takeover defenses and pursue control. Unitrin's board—comprised of a majority of outside directors and advised by investment bankers and counsel—concluded the offer was inadequate and posed a threat of "substantive coercion" (i.e., that stockholders might tender based on an undervaluation of Unitrin's long-term prospects). The board maintained Unitrin's shareholder rights plan (poison pill) and adopted a substantial open-market stock repurchase program intended to increase the percentage of shares held by Unitrin and its insiders, thereby raising the hurdle AGC would face in a proxy contest or later control transaction. AGC sued in the Delaware Court of Chancery for injunctive relief. The Court of Chancery found the board had shown a cognizable threat, but held that the repurchase program, when combined with the rights plan and Unitrin's governance structure (including a classified board), was effectively preclusive of a successful proxy contest and therefore impermissible under Unocal. It enjoined the repurchase and granted preliminary relief. Unitrin appealed.
Under Unocal's intermediate standard of review, when a board faces a hostile bid it deems inadequate, are a poison pill and a substantial stock repurchase program impermissible "draconian" defenses because they are preclusive or coercive, or can they be upheld as within the range of reasonableness in relation to the threat posed?
Under Unocal, directors who adopt defensive measures must first show they had reasonable grounds for believing a danger to corporate policy and effectiveness existed. If they do, the burden shifts to show the response was reasonable in relation to the threat. Defensive measures that are coercive (coerce or force stockholders to accept management's preferred alternative) or preclusive (render a successful proxy contest or tender offer realistically unattainable or a near impossibility) are "draconian" and per se invalid. If a defense is not coercive or preclusive, courts assess whether it falls within a "range of reasonableness" in relation to the threat; boards are not required to adopt the least restrictive alternative. "Substantive coercion"—the risk that stockholders will mistakenly accept an inadequate offer—is a legitimate threat a board may address.
The Delaware Supreme Court affirmed that Unitrin's board identified a legitimate threat (including substantive coercion), but reversed the Court of Chancery's conclusion that the board's repurchase plan was preclusive under an overly expansive definition. It held that defenses are preclusive only if they render a successful proxy contest or tender offer realistically unattainable. Because the record did not establish preclusion or coercion as a matter of law, the Court remanded for the Court of Chancery to determine whether the repurchase program, together with the pill, fell within the range of reasonableness in relation to the threat posed.
The Court began by reaffirming Unocal's two-step framework. First, it agreed that the Unitrin board reasonably perceived a threat, crediting the board's reliance on expert financial advice suggesting AGC's offer undervalued Unitrin and recognizing substantive coercion as a cognizable risk. Next, the Court refined the proportionality prong by clarifying that a defensive measure is per se invalid only if it is "draconian"—that is, coercive or preclusive. It defined coercion as a measure that forces stockholders to accept management's choice and preclusion as one that renders a successful proxy contest or tender offer realistically unattainable. The Court emphasized that making a contest "more difficult" is not the same as making it unattainable; the Court of Chancery erred by equating substantial impediment with preclusion. The Supreme Court also rejected a "least-restrictive-means" requirement; the proper inquiry is whether non-draconian measures fall within a range of reasonableness relative to the identified threat. Applying those principles, the Court held the record did not justify the conclusion that Unitrin's repurchase would inevitably create an insurmountable management bloc or make a proxy victory for AGC virtually impossible. Because the measures were not shown to be coercive or preclusive per se, the analysis turned to whether they were reasonable responses within the permissible range, an inquiry the Court remanded to the Court of Chancery to conduct under the corrected standards.
Unitrin is a bedrock case in Delaware takeover jurisprudence. It (1) entrenches substantive coercion as a legitimate threat; (2) supplies precise definitions of "coercive" and "preclusive" defenses; (3) rejects any requirement that boards adopt the least restrictive alternative; and (4) articulates the "range of reasonableness" test that has become the backbone of Unocal proportionality review. The opinion gives boards practical room to use pills and buybacks to counter inadequate bids, while equipping courts to strike down truly draconian measures. It has been repeatedly cited in later cases (e.g., Unocal progeny and Air Products v. Airgas) and is essential for understanding modern M&A defense law and board fiduciary duties in change-of-control contexts.
Unitrin clarifies that after directors establish a legitimate threat, defensive measures are invalid per se only if they are "draconian"—coercive or preclusive. If not draconian, courts ask whether the response falls within a "range of reasonableness" in relation to the threat. Unitrin also confirms that boards need not choose the least restrictive alternative and that substantive coercion is a valid threat.
A defense is preclusive if it renders a successful proxy contest or tender offer realistically unattainable or a near impossibility, not merely more difficult. A defense is coercive if it forces or pressures stockholders to accept the board's preferred option (for example, by structuring a vote or transaction to penalize rejection).
Substantive coercion refers to the risk that stockholders, misunderstanding the company's intrinsic value or future prospects, might tender into or approve an inadequate offer. Unitrin recognizes this as a legitimate threat that boards may counter with reasonable defenses, such as maintaining a poison pill or undertaking a buyback, subject to Unocal review.
No. The Delaware Supreme Court expressly rejected a least-restrictive-means requirement. Once a defense is found not to be coercive or preclusive, the question is whether it falls within a reasonable range of responses to the threat identified. Multiple reasonable options may exist, and boards are not confined to the least burdensome one.
Unitrin confirms that both poison pills and repurchase programs can be lawful defensive measures if they address a legitimate threat and are not coercive or preclusive. Even if not draconian, they still must be proportionate—i.e., within the range of reasonableness—given the company's circumstances and the threat posed by the bid.
Courts frequently cite Unitrin to evaluate whether defensive measures cross the line from permissible to draconian and to apply the range-of-reasonableness test. Notably, in Air Products v. Airgas, the Court of Chancery relied on Unitrin's recognition of substantive coercion and its framework to uphold a board's maintenance of a poison pill against a hostile tender offer deemed inadequate.
Unitrin marks a pivotal refinement of Delaware's takeover defense doctrine by delineating the boundaries of board discretion under Unocal. By confining per se invalidity to truly coercive or preclusive measures and adopting a flexible range-of-reasonableness inquiry for all others, the Court preserved meaningful board authority to resist inadequate bids without sanctioning entrenchment.
For law students and practitioners, Unitrin is indispensable reading. It operationalizes the balance at the core of Delaware fiduciary law—empowering informed, good-faith board decision-making while ensuring that defensive tactics remain proportionate to genuine threats and do not foreclose stockholder choice.
Need to cite this case?
Generate a perfectly formatted Bluebook citation in seconds.
Use our Bluebook Citation Generator →